Hemoadsorption: Consensus report of the 30th Acute Disease Quality Initiative workgroup.
Ankawi G, Bagshaw SM, Bellomo R, Baldwin I, Basu R, Bottari G, Cantaluppi V, Clark W, De Rosa S, Forni LG, Fuhrman D, Goldstein S, Gomez H, Husain-Syed F, Joannidis M, Kashani K, Lorenzin A, Mehta R, Murray PT, Murugan R, Ostermann M, Pannu N, Premuzic V, Prowle J, Reis T, Rimmelé T, Ronco C, Rosner M, Schneider A, See E, Soranno D, Villa G, Whaley-Connell A, Zarbock A.
Ankawi G, et al. Among authors: forni lg.
Nephrol Dial Transplant. 2024 Apr 15:gfae089. doi: 10.1093/ndt/gfae089. Online ahead of print.
Nephrol Dial Transplant. 2024.
PMID: 38621759
The data show that hemoadsorption has clinically acceptable short-term biocompatibility and safety, technical feasibility, and experimental demonstration of specified target molecule removal. ...
The data show that hemoadsorption has clinically acceptable short-term biocompatibility and safety, technical feasibility, and experi …